PDF(Pubmed)
Abstract：
to carry out a scoping review with the purpose of mapping the scientific evidence on the use of the neutropenic diet in neutropenic pediatric cancer patients.
The scoping review protocol was prepared in accordance with the PRISMA-ScR and the checklist before the literature search was performed. Articles on nutritional management in adults or on the treatment of other diseases, and articles that were not in Portuguese or English and published before the year 2000, were excluded. Data were extracted based on the Cochrane Consumer and Communication Review Group form.
Three hundred and forty scientific articles were identified, with the final sample of this review consisting of nine studies. Although the neutropenic diet has been part of the nutritional management of pediatric cancer patients for more than 20 years, there is still great variation in the criteria for indicating use and starting and discontinuing it, as well as in the nutritional composition of the diet. Furthermore, there is no consensus on the impact of using a neutropenic diet on different clinical and nutritional outcomes.
In the absence of guidelines that standardize the use of a neutropenic diet in pediatric patients with neutropenia, there are heterogeneous approaches reported in the literature, even within the same institution. The available literature presents an absence of evidence on the use, viability, and effectiveness of the neutropenic diet in oncological children with neutropenia. More studies are needed to identify the real impact of the neutropenic diet on clinical and nutritional outcomes.
The scoping review protocol was prepared in accordance with the PRISMA-ScR and the checklist before the literature search was performed. Articles on nutritional management in adults or on the treatment of other diseases, and articles that were not in Portuguese or English and published before the year 2000, were excluded. Data were extracted based on the Cochrane Consumer and Communication Review Group form.
Three hundred and forty scientific articles were identified, with the final sample of this review consisting of nine studies. Although the neutropenic diet has been part of the nutritional management of pediatric cancer patients for more than 20 years, there is still great variation in the criteria for indicating use and starting and discontinuing it, as well as in the nutritional composition of the diet. Furthermore, there is no consensus on the impact of using a neutropenic diet on different clinical and nutritional outcomes.
In the absence of guidelines that standardize the use of a neutropenic diet in pediatric patients with neutropenia, there are heterogeneous approaches reported in the literature, even within the same institution. The available literature presents an absence of evidence on the use, viability, and effectiveness of the neutropenic diet in oncological children with neutropenia. More studies are needed to identify the real impact of the neutropenic diet on clinical and nutritional outcomes.
摘要：
目的：进行范围审查，目的是为中性粒细胞减少症儿童癌症患者使用中性粒细胞减少症饮食的科学证据作图。
方法：在进行文献检索之前，根据PRISMA-ScR和清单制定范围审查方案。关于成人营养管理或其他疾病治疗的文章，在2000年之前发表的不是葡萄牙语或英语的文章被排除在外。数据是根据Cochrane消费者和沟通审查小组表格提取的。
结果：确定了三百四十篇科学论文，本综述的最终样本由9项研究组成。尽管中性粒细胞减少饮食已经成为儿科癌症患者营养管理的一部分超过20年，指示使用以及开始和停止使用的标准仍然存在很大差异，以及饮食的营养成分。此外，对于使用中性粒细胞减少性饮食对不同临床和营养结局的影响尚无共识.
结论：由于缺乏规范中性粒细胞减少症患儿使用中性粒细胞减少症饮食的指南，文献中报道了不同的方法，即使在同一机构内。现有的文献表明，缺乏使用的证据，生存能力，和有效性的中性粒细胞减少症的肿瘤儿童的饮食。需要更多的研究来确定中性粒细胞减少饮食对临床和营养结果的真正影响。
方法：在进行文献检索之前，根据PRISMA-ScR和清单制定范围审查方案。关于成人营养管理或其他疾病治疗的文章，在2000年之前发表的不是葡萄牙语或英语的文章被排除在外。数据是根据Cochrane消费者和沟通审查小组表格提取的。
结果：确定了三百四十篇科学论文，本综述的最终样本由9项研究组成。尽管中性粒细胞减少饮食已经成为儿科癌症患者营养管理的一部分超过20年，指示使用以及开始和停止使用的标准仍然存在很大差异，以及饮食的营养成分。此外，对于使用中性粒细胞减少性饮食对不同临床和营养结局的影响尚无共识.
结论：由于缺乏规范中性粒细胞减少症患儿使用中性粒细胞减少症饮食的指南，文献中报道了不同的方法，即使在同一机构内。现有的文献表明，缺乏使用的证据，生存能力，和有效性的中性粒细胞减少症的肿瘤儿童的饮食。需要更多的研究来确定中性粒细胞减少饮食对临床和营养结果的真正影响。
